Botanical species · safety record

Eremanthus arboreus

The EFSA Compendium of Botanicals holds 5 constituent measurements for Eremanthus arboreus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Eremanthus arboreus (Gardner) MacLeish

5Constituent measurements

0Safety records

3Cited sources

0Licensed products (Canada)

Also recorded as

Vanillosmopsis arborea (Gardner) Baker

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Elemicin	Bark	Essential oil	2.68 Percent	GC-MS	Resolve DOI
Estragole	Bark	Essential oil	3.65 Percent	GC-MS	Resolve DOI
Methyleugenol	Bark	Essential oil	5.91 Percent	GC-MS	Resolve DOI
Sesquiterpene lactones	Aerial part of plants	—	—	—	Resolve DOI
Sesquiterpene lactones	Aerial part of plants	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Craveiro, A.A., Alencar, J.W., Matos, F.J.A., Sousa, M.P., Machado, M.I.L. Volatile constituents of leaves, bark and wood from Vanillosmopsis arborea baker. Journal of essential oil research, 1989, vol. 1, no. 6, p. 293-294. DOI
Koch, E., Klaas, CA., Rungeler, P., Castro, V., Mora, G., Vichnewski, W., Merfort, I. Inhibition of inflammatory cytokine production and lymphocyte proliferation by structurally different sesquiterpene lactones correlates with their effect on activation of NF-kappa B . Biochemical pharmacology, 2001, vol. 62, no. 6, p. 795-801. DOI
Vichnewski, W., Skrochy, CA., Maria, A., Nasi, TT., Lopes, JLC., Herz, W. 15-hydroxyeremantholide B and derivatives from Eremanthus arboreus. Phytochemistry, 1999, vol. 50, no. 2, p. 317-320. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature